This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Feb;2010(2):pdb.prot5372.

doi: 10.1101/pdb.prot5372.

Calcium phosphate transfection of 3T3 fibroblasts

Stephen T Smale

PMID: 20150135
DOI: 10.1101/pdb.prot5372

Calcium phosphate transfection of 3T3 fibroblasts

Stephen T Smale. Cold Spring Harb Protoc. 2010 Feb.

. 2010 Feb;2010(2):pdb.prot5372.

doi: 10.1101/pdb.prot5372.

Author

Stephen T Smale

PMID: 20150135
DOI: 10.1101/pdb.prot5372

No abstract available

PubMed Disclaimer

Similar articles

The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection.
Pedraza CE, Bassett DC, McKee MD, Nelea V, Gbureck U, Barralet JE. Pedraza CE, et al. Biomaterials. 2008 Aug;29(23):3384-92. doi: 10.1016/j.biomaterials.2008.04.043. Epub 2008 May 16. Biomaterials. 2008. PMID: 18485472
p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts.
Renzing J, Lane DP. Renzing J, et al. Oncogene. 1995 May 4;10(9):1865-8. Oncogene. 1995. PMID: 7753562
Addition of glycerol during DNA exposure enhances calcium phosphate transfection.
Wilson SP, Smith LA. Wilson SP, et al. Anal Biochem. 1997 Mar 1;246(1):148-50. doi: 10.1006/abio.1997.2005. Anal Biochem. 1997. PMID: 9056201 No abstract available.
Transfection of Mammalian Cells with Calcium Phosphate-DNA Coprecipitates.
Kumar P, Nagarajan A, Uchil PD. Kumar P, et al. Cold Spring Harb Protoc. 2019 Oct 1;2019(10). doi: 10.1101/pdb.top096255. Cold Spring Harb Protoc. 2019. PMID: 31575800 Review.
Calcium phosphate nanoparticles for the transfection of cells.
Kovtun A, Heumann R, Epple M. Kovtun A, et al. Biomed Mater Eng. 2009;19(2-3):241-7. doi: 10.3233/BME-2009-0586. Biomed Mater Eng. 2009. PMID: 19581719 Review.

See all similar articles

Cited by

CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials.
Lin A, Giuliano CJ, Sayles NM, Sheltzer JM. Lin A, et al. Elife. 2017 Mar 24;6:e24179. doi: 10.7554/eLife.24179. Elife. 2017. PMID: 28337968 Free PMC article.
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.
Lin A, Giuliano CJ, Palladino A, John KM, Abramowicz C, Yuan ML, Sausville EL, Lukow DA, Liu L, Chait AR, Galluzzo ZC, Tucker C, Sheltzer JM. Lin A, et al. Sci Transl Med. 2019 Sep 11;11(509):eaaw8412. doi: 10.1126/scitranslmed.aaw8412. Sci Transl Med. 2019. PMID: 31511426 Free PMC article.
MELK expression correlates with tumor mitotic activity but is not required for cancer growth.
Giuliano CJ, Lin A, Smith JC, Palladino AC, Sheltzer JM. Giuliano CJ, et al. Elife. 2018 Feb 8;7:e32838. doi: 10.7554/eLife.32838. Elife. 2018. PMID: 29417930 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire